While pharma won’t have any real power to resist fees, there is no doubt that payment will change the relationship, and open up NICE to further scrutiny and pressure for change. UK pharma ...

NICE has re-drafted new guidelines for type 2 diabetes treatments after a major backlash from doctors – but critics say the second attempt is still badly flawed. The UK's National Institute for ...

UK health technology assessor the National Institute for Health and Care Excellence (NICE) has issued Final Draft Guidance ...

The UK pharma industry can expect resolutions on a range of issues ... Streeting projected reform to drug approvals by the National Institute for Health and Care Excellence (NICE) under its chief ...

The UK’s National Institute for Health and Care Excellence (NICE) has recommended AstraZeneca’s (LSE: AZN) Truqap ...

Accord UK (citalopram, fluoxetine, paroxetine) (confidentiality agreement not signed, not participating) ADVANZ Pharma (citalopram, fluoxetine, venlafaxine) (confidentiality agreement not signed, not ...

UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline. It's used by horizon scanning organisations, including NICE, to help plan and prepare the NHS ...

Bristol Myers Squibb (BMS) has announced that its dual immunotherapy combination has been recommended by the National ...